The impressive growth in
biologics has attracted top-tier
pharma companies to the
biogenerics arena.
Despite the significant costs
and hurdles expected in
developing and gaining
approval for such products,...
The rise in counterfeit medicines worldwide, with concomitant problems of toxicity, instability and ineffectiveness, is often underestimated...
The pharmaceutical industry is facing a tough road ahead in the future marketplace. Though pharmaceuticals remain the most costeffective healthcare intervention,...
Vaccines play a central role in health protection and advances in biotechnologies now offers numerous novel approaches for vaccine development...
Understanding the solubility behaviour of the drugexcipient complex in a lipid-based drug delivery system will help...
Although conventional freeze drying in vials is still the predominant format, lyophilisation in alternative formats, such as pre-filled syringes,...
This is a case study of how Amgen manages a major electronic Common Technical Document filing. It focusses on tools and processes developed and refined from 2005 to present...
Because R&D productivity is a problem for pharma the partnering opportunities are basically seen in licensing and acquisitions.
India's growing respect and legal / regulatory framework for IPR, favourable economic policies resulting into attractive investment destination and availability of huge talent pool...
In managing Chemistry, Manufacturing and Controls documents, the larger process is involved for electronic regulatory submissions to health authorities...
Alan S Louie
Research Director
Christopher
-Paul Milne
Associate Director
Douglas Meyer
Senior Director
Frank A Jaeger
Director, New Business Development
Georg C Terstappen
Chief Scientific Officer
Kenneth I Kaitin
Director and Professor of Medicine
Laurence Flint
Associate Director
Neil J Campbell
CEO, Mosaigen Inc. and Partner, Endeavour Capital Asia Ltd., USA
Phil Kaminsky
Founder, Center for Biopharmaceutical Operations, University of California, Berkeley, USA
Rustom Mody
Director, Quality and Strategic Research, Intas Biopharmaceuticals
Limited,
India.
Sanjoy Ray
Director, Technology Innovation
Sasikant Misra
Deputy Director, Confederation of Indian Industry, India.
The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer. The industry is only too aware of this and understands that now is the time to look at new processes and a change in the way they have traditionally done business.
Peter Ehrenheim, President & CEO, Life Sciences, GE Healthcare, UK
This volume will provide researchers with recent information on bioactivation reactions of drugs and toxicants...
We postulated that pharmacological targeting of putative stromal support functions, in particular those...
Unigene plans to build pharmaceutical manufacturing plant and R&D centres in China.
Jiangsu Stem Cell Storage and processing facility is to be constructed in Jiangsu province, China.
Researchers at the Massachusetts Institute of Technology have come up with the first fully synthetic...
Researchers at the University of Leeds have come up with a technology that could help the pharmaceutical industry...
A Report by PricewaterhouseCoopers
Pharma is at a pivotal point in its evolution, particularly in relation to R&D.
Pharma Focus Asia, published quarterly, is the leading pharma magazine in print and digital versions covering important issues and trends shaping the future of the Asian pharmaceutical industry.
Pharma's New Worldview
To date, research and development (R&D) within the pharmaceutical industry has been dominated by a developed-market perspective.

31 Aug, 2010
ScinoPharm to Invest in Tanvex Biologics
...
30 Aug, 2010
SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide S
...
25 Aug, 2010
Inspire Announces Amendment to Ophthalmic Collaboration
...

1 Sep, 2010
Generic Drug Sector Gets Better Information on API Manufacturing Costs
...
30 Aug, 2010
Sequella and University of Maryland Restate Exclusive License for Join
...
26 Aug, 2010
Novartis Completes Purchase from Nestlé of Majority Interest in Alcon
...

Sep 6 - Sep 8 2010
LogiPharma China...
Sep 6 - Sep 7 2010
LogiPharma China 2010...
Sep 13 - Sep 16 2010
World Pharma Trials Asia 2010...
I have been very impressed with the quality and timeliness of the articles. Each of...
David R. Webb
Vice President, Research
Signal Pharmaceuticals
LLC, A wholly owned
subsidiary of CELGENE, USA
The magazine looked great and there were excellent articles of huge interest.
Dr Iman El-Hariry
Group Director
Oncology MDC, Europe
GlaxoSmithKline, UK